Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 690 of 6351
-
Could a camera replace the mask in head and neck cancer radiotherapy?
Symptom relief CompletedThe goal of this clinical trial is to test the use of surface repositioning alone, without a restraint mask, during radiotherapy sessions for patients with head and neck cancer.
Sponsor: Center Eugene Marquis • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New hope for myeloma patients too old for transplant?
Disease control Recruiting nowThis study will evaluate efficacy and tolerability of iberdomide, bortezomib, dexamethasone and isatuximab on demand administered in combination for newly diagnosed transplant-ineligible multiple myeloma patients.
Phase 2 • Sponsor: Canadian Myeloma Research Group • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
30,000 volunteers sought to catch pancreatic cancer early
Knowledge-focused Recruiting nowThis study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cure…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New mRNA drug hopes to help cystic fibrosis patients who Can't use current therapies
Disease control Recruiting nowARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to drug intolerance, poor response, or lack of access to modulators.
Phase 2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
CAR-T cells take on progressive MS: early trial launches
Disease control OngoingThis is an open-label, multi-center, non-confirmatory study to assess the safety, disease progression, and cellular kinetics following YTB323 administration to 28 participants with non-active Progressive Multiple Sclerosis (PMS). The study design utilizes an ascending single dose…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Smart armbands could catch strokes before doctors do
Diagnosis Recruiting nowThis trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session w…
Sponsor: Neuralert Technologies LLC • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo shows promise for Tough-to-Treat endometrial cancer
Disease control Recruiting nowThis is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial cancer.
Phase 2 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New HIV pill dose for kids shows promise in african study
Disease control CompletedThis study aims to find out whether treating children living with HIV with three anti-HIV medicines, dolutegravir (DTG), emtricitabine (FTC) and tenofovir alafenamide (TAF), with a novel dose ratio will achieve adequate drug concentrations and is safe. The optimal DTG/FTC/TAF dos…
Phase 2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New Pill-Form fungus fighter takes on deadly candida
Disease control Recruiting nowThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Fosmanogepix) for the potential treatment of candidemia and/or invasive candidiasis, a life-threatening fungal infection caused by several species of yeast called Candida. T…
Phase 3 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Immunotherapy duo takes on cervical cancer in new trial
Disease control OngoingMulticenter, open-label, randomized, seeking signal (non-comparative), Phase II aiming to assess the clinical activity of the combination relatlimab + nivolumab in locally advanced cervical cancer eligible to standard CCRT
Phase 2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New anxiety pill shows promise in Late-Stage trial
Symptom relief OngoingA Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - Voyage
Phase 3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Experimental antibody cocktail takes on Hard-to-Treat myeloma
Disease control Recruiting nowThis study is researching an experimental drug called REGN7945 in combination with another experimental drug called linvoseltamab, (also known as REGN5458) (each individually called a "study drug" or "study drugs" when combined). This study is the first time REGN7945 will be tes…
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new daily pill tame focal seizures?
Disease control CompletedA Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)
Phase 2/3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for ulcerative colitis: phase 3 trial launches
Disease control Recruiting nowThis Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC).
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug duo takes on tough lymphoma
Disease control Recruiting nowTo assess the efficacy and safety of mosunetuzumab combined with zanubrutinib in patients with relapsed or refractory MZL.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Blood test may spot pancreatic cancer early, study hopes
Diagnosis Recruiting nowThe challenge for medical oncology is to develop plasma biomarkers that can detect the influence of the stroma on diagnosis, prognosis and response to chemotherapy. Today, there is no validated blood test to help diagnose pancreatic cancer (PDAC). The search for blood biomarkers…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Sound waves vs. pancreatic cancer: new device tested in humans
Disease control Recruiting nowThe purpose of this trial is to evaluate the safety of the HistoSonics Edison System for the destruction of pancreatic adenocarcinomas using histotripsy.
Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Mindfulness sleep program aims to stop perinatal depression before it starts
Prevention Recruiting nowPerinatal depression (PND) is the most common complication in pregnancy and postpartum, which increases risk for adverse perinatal outcomes such as preterm birth, maternal suicidal thoughts, and impaired mother-infant bonding. Insomnia often precedes PND cases and may serve as an…
Phase 2 • Sponsor: Henry Ford Health System • Aim: Prevention
Last updated Jun 27, 2026 12:09 UTC
-
AI reads your Heart's electrical signals to find hidden blockages
Diagnosis OngoingAI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting coronary blood flow alteration. The aim of the study is to identify electrocard…
Sponsor: Powerful Medical • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Custom stents could replace open surgery for deadly aortic bulges
Disease control Recruiting nowThe primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both…
Sponsor: Bjoern D. Suckow • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC